Prospective Registry of Acute Coronary Syndromes in Ferrara
Launched by UNIVERSITY HOSPITAL OF FERRARA · May 5, 2015
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The ARYOSTO trial is a study looking at how patients with acute coronary syndromes (ACS) are treated in the Ferrara area of Italy. ACS includes conditions like heart attacks, where quick medical care is critical. This trial aims to gather information about the types of treatments patients receive, especially focusing on those who undergo procedures like coronary angiography and stenting to open blocked arteries. By understanding these treatments better, healthcare providers hope to improve care for future patients.
To join this trial, participants need to be at least 18 years old, living in the Ferrara area, and have been admitted to the hospital for acute coronary syndromes. There are no specific health conditions that would exclude someone from participating. Patients who take part can expect to have their treatment and recovery closely monitored, which may help contribute to better heart care for everyone in the community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age \>18 years
- • hospital admission for acute coronary syndromes
- • resident in the Ferrara area
- Exclusion Criteria:
- • none
About University Hospital Of Ferrara
The University Hospital of Ferrara, a leading academic medical institution in Italy, is dedicated to advancing healthcare through innovative research and clinical excellence. Affiliated with the University of Ferrara, the hospital is known for its commitment to integrating cutting-edge scientific inquiry with patient care. With a multidisciplinary approach, the institution conducts a wide range of clinical trials aimed at enhancing treatment methodologies and improving patient outcomes in various medical fields. The University Hospital of Ferrara prioritizes ethical standards and patient safety, fostering a collaborative environment that engages researchers, healthcare professionals, and patients in the pursuit of medical advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cona, Ferrara, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials